Dark

Check out our Dark Pool Levels

CEMI
Chembio diagnostics, Inc.
stock NASDAQ

Inactive

Apr 27, 2023

0.4550USD+0.220%(+0.0010)351,642

Pre-market

0.00USD-100.000%(-0.45)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 6, 2022

04:05PM EST Chembio Diagnostics Reports Inducement Award Under Nasdaq Listing GlobeNewswire Inc

Jan 5, 2022

04:06PM EST Chembio Dianostics Names Larry Steevoorden CFO Benzinga

04:05PM EST Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the appointment of Larry Steenvoorden as Chief Financial Officer effective immediately. GlobeNewswire Inc

Dec 30, 2021

07:30AM EST CIBC Asset Management announces revised December 2021 cash distributions for PR Newswire

Dec 29, 2021

12:23PM EST CIBC Asset Management announces final 2021 annual reinvested capital gains PR Newswire

Dec 22, 2021

02:35PM EST FDA Website Shows Dec. 22-Dated update On Antigen Tests For Omicron: 'The FDA continues to monitor and evaluate the impact of genetic variants on antigen tests...' Benzinga

Dec 8, 2021

06:19AM EST Chembio Diagnostics Says O Dec. 1 Received Notice From FDA That FDA Would Require Additional Data Related To Clinical Laboratory Improvement Amendment Waiver Submission For DPP HIV-Syphilis Test System Benzinga

Dec 6, 2021

08:03AM EST Chembio Diagnostics Submits FDA De Novo/510(k) Request For DPP SARS-CoV-2 Antigen Test System Benzinga

08:01AM EST Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has submitted a De Novo/510(k) Request to the U.S. Food and Drug Administration (FDA) for the DPP SARS-CoV-2 Antigen test system. GlobeNewswire Inc

07:30AM EST CIBC Asset Management announces estimated 2021 annual reinvested capital gains PR Newswire

Nov 29, 2021

08:05AM EST Chembio Diagnostics Receives SAHPRA Approval For DPP SARS-CoV-2 Antigen Test Benzinga

08:00AM EST Chembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 GlobeNewswire Inc

Nov 22, 2021

08:00AM EST Chembio Diagnostic Systems Inc. (Chembio), a subsidiary of Chembio Diagnostics, Inc. (Nasdaq: CEMI), received an international arbitration award Thursday, November 18, 2021 against BioSure (UK) Ltd, Chembios former UK distributor of HIV self-tests. GlobeNewswire Inc

Nov 17, 2021

07:53AM EST The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment Benzinga

Nov 16, 2021

04:06PM EST Chembio Reports Submission Of Emergency Use Authorization For New SARS-CoV-2 Antigen Test Benzinga

04:05PM EST Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for the new DPP SARS-CoV-2 Antigen test. GlobeNewswire Inc

Nov 15, 2021

11:06AM EST Chembio Diagnostics Announces Extension Of Delivery Schedule For Bio Manguinhos Purchase Order Of DPP SARS-COV-2 Antigen Tests Benzinga

08:00AM EST Chembio Diagnostics Announces Extension of Delivery Schedule for GlobeNewswire Inc

Nov 11, 2021

06:32AM EST Chembio Diagnostic Systems Filed U.S. Patent Application #20210349083 'CORONAVIRUS IgG/IgM MULTIPLEXED DUAL PATH IMMUNOASSAY DEVICE' Benzinga

Nov 5, 2021

09:43AM EDT The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill Benzinga

09:29AM EDT Chembio Diagnostics Q3 EPS $(0.24) Misses $(0.22) Estimate, Sales $12.10M Beat $11.50M Estimate Benzinga

Nov 4, 2021

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Oct 7, 2021

02:00PM EDT TMX Group Equity Financing Statistics - September 2021 PR Newswire

Sep 22, 2021

08:04AM EDT Chembio Announces EUA Submission For DPP Respiratory Antigen Panel Benzinga

08:00AM EDT Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application to the Food and Drug Administration (FDA) for the companys DPP Respiratory Antigen Panel test system. GlobeNewswire Inc

Sep 16, 2021

07:33AM EDT CIBC Asset Management Launches New Index ETFs RTTNews

Aug 31, 2021

11:37AM EDT Return on Capital Employed Insights for Chembio Diagnostics Benzinga

Aug 30, 2021

05:51AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.36 A.M. EDT). RTTNews

Aug 27, 2021

03:43PM EDT Why Chembio Diagnostics Shares Are Trading Higher Today Benzinga

08:01AM EDT Chembio Launches Commercial Distribution Of SCoV-2 Ag Detect Rapid Test Benzinga

08:00AM EDT Chembio Launches Commercial Distribution of Third-Party COVID-19 GlobeNewswire Inc

Aug 9, 2021

05:03PM EDT Chembio Diagnostics Filing Shows Registration For $60M Common Stock Offering Benzinga

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

05:30PM EDT Chembio Diagnostics Q2 EPS $(0.45) Misses $(0.27) Estimate, Sales $6.46M Miss $8.53M Estimate Benzinga

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 3, 2021

12:58PM EDT Chembio Diagnostics Shares Move Higher; Traders Circulate FDA Report Showing Emergency Use Authorization For Co's COVID Antibodies Test Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 22, 2021

02:21PM EDT Chembio To Ship $4M Of WHO-Qualified HIV Test Kits To Ethiopia In 2022 Benzinga

12:50PM EDT Chembio Diagnostics Receives $4M HIV Test Purchase Order Supported By The Global Fund Benzinga

12:50PM EDT Chembio Diagnostics Receives $4 Million HIV Test Purchase Order GlobeNewswire Inc

Jul 21, 2021

02:39PM EDT Chembio Diagnostics Shares Up 200%; Hearing Collier Downgrades To Neutral Benzinga

12:15PM EDT Mid-Day Market Update: Crude Oil Up 4%; Chembio Diagnostics Shares Spike Higher Benzinga

10:47AM EDT Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Views Benzinga

10:25AM EDT CEMI Chembio Diagnostics Option Alert: Aug 20 $5 Calls Sweep (3) near the Ask: 295 @ $1.45 vs 1860 OI; Earnings 8/5 After Close [est] Ref=$5.375 Benzinga

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

05:36AM EDT Chembio Stock More Than Doubles On $28M Purchase Order For Its COVID Antigen Tests Benzinga

05:21AM EDT Chembio Diagnostics Shares Rise 100%+ in Premarket; Co Announced Late Tuesday it Received $28.3M Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil Benzinga

Jul 20, 2021

10:56PM EDT Chembio Diagnostics Receives $28.3 Million Purchase Order from GlobeNewswire Inc

Jul 19, 2021

05:31PM EDT UPDATE: Chembio Filing Shows Registration For $60M Common Stock Offering Benzinga

05:24PM EDT Chembio Diagnostics 8-K Shows At The Market Offering Of Common Stock, No Size Disclosed Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 9, 2021

07:36AM EDT The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO Benzinga

Jul 8, 2021

07:45AM EDT The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test Benzinga

Jul 7, 2021

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jun 23, 2021

07:35AM EDT The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

May 26, 2021

07:33AM EDT The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing Benzinga

May 6, 2021

05:05PM EDT Chembio Diagnostics Q1 EPS $(0.22) Beats $(0.32) Estimate, Sales $8.70M Beat $8.19M Estimate Benzinga

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 22, 2021

08:00AM EDT Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the first quarter of 2021 after the close of trading on Thursday, May 6, 2021. GlobeNewswire Inc

Apr 5, 2021

02:31PM EDT Mid-Afternoon Market Update: Crude Oil Down 4.5%; Chembio Diagnostics Shares Spike Higher Benzinga

02:16PM EDT Mid-Day Market Update: Leaf Group Jumps Following Acquisition News; ACADIA Pharmaceuticals Shares Slide Benzinga

10:17AM EDT Mid-Morning Market Update: Markets Open Higher; ISM Services PMI Surges To Record High Benzinga

Apr 1, 2021

05:30PM EDT Chembio Announces U.S. Commercial Launch of Diagnostic Tool to GlobeNewswire Inc

Mar 31, 2021

07:30AM EDT CIBC Asset Management launches new Index ETFs PR Newswire

Mar 15, 2021

06:36AM EDT Chembio Diagnostics Files for $100M Mixed Offering Benzinga

Mar 12, 2021

07:36AM EST The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs Benzinga

Mar 11, 2021

04:24PM EST Chembio Diagnostics Q4 EPS $(0.35) Misses $(0.28) Estimate, Sales $10.20M Beat $5.77M Estimate Benzinga

04:05PM EST Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter and year ended December 31, 2020. GlobeNewswire Inc

08:19AM EST The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena Benzinga

03:35AM EST Earnings Scheduled For March 11, 2021 Benzinga

Mar 10, 2021

10:13AM EST Chembio Diagnostics's Earnings Outlook Benzinga

Mar 8, 2021

08:46AM EST Chembio Diagnostics Appoints David Bespalko To Its Board RTTNews

08:46AM EST Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Bespalko to the Companys Board of Directors, effective upon his election on March 4, 2021. GlobeNewswire Inc

Mar 6, 2021

10:58AM EST The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings Benzinga

Jan 15, 2021

03:52PM EST Chembio Diagnostics Wins Department Of Agriculture Contract Titled 'DPP VET TB CERVID KITS' Benzinga

Jan 14, 2021

07:02AM EST Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems Benzinga

07:00AM EST Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen GlobeNewswire Inc

Jan 13, 2021

06:15AM EST UPDATE: Chembio Partner LumiraDx Says Its SARS-CoV-2 Antigen Test Achieved 87-90% Agreement With RT-PCR Which Increased To 92-95% In Patients With Viral Load Benzinga

06:14AM EST Chembio COVID-19 Strategic Partner LumiraDx Earlier Announced Scandinavian Evaluation Of Lab Equipment For Point-of-Care Testing Published Positive Evaluation Of LumiraDx SARS-CoV-2 Antigent Test Benzinga

Dec 17, 2020

04:05PM EST Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Companys Board of Directors. GlobeNewswire Inc

Dec 7, 2020

11:34AM EST Chembio Diagnostics In Friday SEC Filing Said The FDA Ruled The Co's 'IgM/IgG' Emergency Use Authorization Request Is 'Not A Priority;' Benzinga

Dec 4, 2020

12:59PM EST Shares of Chembio Diagnostics, Inc. (CEMI) were falling more than 17% Friday morning at $6.17. RTTNews

06:19AM EST Chembio Diganostics 8-K Shows Co. Wins $12.7M By Biomedical Advanced Research and Development Authority For Development Of Rapid DPP Respiratory Antigen Panel, 510(k) Submission Benzinga

Dec 2, 2020

01:26PM EST Chembio Diagnostics Awarded $12.7M By BARDA For Development Of Rapid DPP Respieratory Antigen Panel, 510(k) Submission Of The Rapid DPP Coronavirus Antigen Test System Benzinga

01:23PM EST Chembio Diagnostics Awarded $12.7 Million by BARDA for Development GlobeNewswire Inc

Nov 13, 2020

04:44PM EST Chembio Diagnostics Receives ANVISA Approval For DPP SARS-CoV-2 Antigen Test System In Brazil Benzinga

04:40PM EST Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that its subsidiary Chembio Diagnostics Brazil Ltda. has received regulatory approval from Agncia Nacional de Vigilncia Sanitria (ANVISA) to market the DPP SARS-CoV-2 Antigen test system in Brazil. GlobeNewswire Inc

Nov 5, 2020

05:25PM EST Chembio Diagnostics Q3 EPS $(0.28) Misses $(0.26) Estimate, Sales $10.30M Beat $3.91M Estimate Benzinga

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 23, 2020

08:00AM EDT Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter 2020 after the close of trading on Thursday, November 5, 2020. GlobeNewswire Inc

Oct 15, 2020

09:11PM EDT Chembio Diagnostics Submits EUA Application For DPP SARS-CoV-2 Antigen Test System RTTNews

05:55PM EDT Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 GlobeNewswire Inc

Oct 2, 2020

10:10AM EDT Return On Capital Employed Overview: Chembio Diagnostics Benzinga

10:10AM EDT Chembio Diagnostics shares are trading higher after the company announced the FDA has approved the Premarket Approval application for the DPP HIV-Syphilis System. Benzinga

07:41AM EDT Chembio Diagnostics Receives FDA Approval For DPP HIV-Syphilis System RTTNews

Sep 9, 2020

10:57AM EDT Chembio Diagnostics shares are trading higher after the company announced it has submitted an application to the FDA for emergency use authorization for its new rapid antibody test system, DPP SARS-CoV-2 IgM/IgG. Benzinga

Sep 8, 2020

06:01PM EDT Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its initiation of the notification process and submission of an application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its new rapid antibody test system, DPP SARS-CoV-2 IgM/IgG. GlobeNewswire Inc

06:01PM EDT Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System Benzinga

Aug 19, 2020

10:37AM EDT Chembio Partner LumiraDx Antigen Test Given FDA EUA Approval; Shares Move Higher Benzinga

Aug 17, 2020

07:43AM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 16, 2020, inclusive (the Class Period), of the important August 17, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Chembio investors under the federal securities laws. GlobeNewswire Inc

Aug 15, 2020

05:50PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

Aug 14, 2020

10:18AM EDT KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline GlobeNewswire Inc

08:31AM EDT Class Action Lawsuit Filed Against Chembio Diagnostics, Inc. (CEMI) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire

Aug 13, 2020

01:00PM EDT Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingAugust 17, 2020deadline to file a lead plaintiff motion in the class action filed on behalf of Chembio Diagnostics, Inc. ("Chembio" or the "Company") (NASDAQ: CEMI) common stock between March 12, 2020 and June 16, 2020, inclusive (the Class Period). GlobeNewswire Inc

09:00AM EDT The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases. GlobeNewswire Inc

Aug 12, 2020

04:30PM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 16, 2020, inclusive (the Class Period), of the important August 17, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Chembio investors under the federal securities laws. GlobeNewswire Inc

11:30AM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

11:00AM EDT CEMI DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds GlobeNewswire Inc

Aug 11, 2020

11:00AM EDT CEMI UPCOMING DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020 Business Wire

Aug 10, 2020

12:24PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

11:00AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Aug 7, 2020

08:24PM EDT Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class PR Newswire

05:45PM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 16, 2020, inclusive (the Class Period), of the important August 17, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Chembio investors under the federal securities laws. GlobeNewswire Inc

Aug 6, 2020

05:11PM EDT Chembio Diagnostics Q2 EPS $(0.42) Misses $(0.39) Estimate, Sales $5.11M Miss $6.88M Estimate Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Aug 5, 2020

02:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

11:00AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Aug 4, 2020

12:00PM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

11:00AM EDT CEMI SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds GlobeNewswire Inc

08:00AM EDT SHAREHOLDER DEADLINES APPROACHING for CEMI, PRA, and JCOM: Block & GlobeNewswire Inc

Aug 3, 2020

04:31PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds GlobeNewswire Inc

Aug 2, 2020

10:35AM EDT LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact PR Newswire

Jul 29, 2020

04:00PM EDT Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of those who acquired Chembio Diagnostics, Inc. (Chembio or the Company) (NASDAQ: CEMI) securities during the period from March 12, 2020 through June 16, 2020. GlobeNewswire Inc

04:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

Jul 28, 2020

01:45PM EDT Inc. Investors of Important August 17 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CEMI PR Newswire

01:00PM EDT CEMI SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds GlobeNewswire Inc

12:00PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

05:00AM EDT Investors with losses of $1,000,000 or more are encouraged to contact the firm for a complimentary case evaluation, click here to submit your transaction information. GlobeNewswire Inc

Jul 27, 2020

07:47PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

02:43PM EDT Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI) from March 12, 2020 through June 16, 2020, inclusive (the Class Period). The lawsuit seeks to recover damages for Chembio Diagnostics, Inc. investors under the federal securities laws. GlobeNewswire Inc

Jul 26, 2020

04:45PM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 16, 2020, inclusive (the Class Period), of the important August 17, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Chembio investors under the federal securities laws. GlobeNewswire Inc

Jul 24, 2020

06:06PM EDT Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against PR Newswire

11:23AM EDT Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 16, 2020, inclusive (the Class Period). The lawsuit seeks to recover damages for investors under the federal securities laws. GlobeNewswire Inc

11:00AM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Jul 23, 2020

04:10PM EDT Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the second quarter 2020 after the close of trading on Thursday, August 6, 2020. GlobeNewswire Inc

Jul 22, 2020

04:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

01:35PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Jul 21, 2020

08:01AM EDT The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Chembio Diagnostic System, Inc. (Chembio or the Company) investors that acquired Chembio securities (NASDAQ: CEMI) betweenApril 1, 2020 through June 16, 2020, inclusive (the "Class Period"). GlobeNewswire Inc

Jul 18, 2020

12:00PM EDT Lawsuit Filed Against Chembio Diagnostics, Inc. (CEMI) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire

Jul 17, 2020

06:20PM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 16, 2020, inclusive (the Class Period), of the important August 17, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Chembio investors under the federal securities laws. GlobeNewswire Inc

11:00AM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Jul 16, 2020

04:55PM EDT Scott+Scott Attorneys at Law LLP Reminds Investors of Securities GlobeNewswire Inc

12:00PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

12:00PM EDT SHAREHOLDER DEADLINES APPROACHING for HEBT, CEMI, and PRA: Block & GlobeNewswire Inc

Jul 15, 2020

07:01PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

05:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

04:49AM EDT 55 Biggest Movers From Yesterday Benzinga

Jul 14, 2020

08:08PM EDT Kessler Topaz Meltzer & Check, LLP Reminds Chembio Diagnostics, GlobeNewswire Inc

02:58PM EDT Chembio Shares Spike Higher After Traders Circulate Positive Coronavirus Antibody Serum News Benzinga

05:11AM EDT 80 Biggest Movers From Yesterday Benzinga

Jul 13, 2020

11:05AM EDT Chembio Diagnostics Option Alert: Fri $5 Calls Sweep (10) near the Ask: 390 @ $0.648 vs 8653 OI; Earnings 8/4 After Close [est] Ref=$5.0899 Benzinga

08:00AM EDT Investors with losses of $1,000,000 or more are encouraged to contact the firm for a complimentary case evaluation, click here to submit your transaction information. GlobeNewswire Inc

Share